Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 4
2009 5
2010 6
2011 11
2012 8
2013 12
2014 8
2015 7
2016 1
2017 3
2018 4
2019 3
2020 3
2021 24
2022 39
2023 39
2024 25

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

181 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.
Falsey AR, Sobieszczyk ME, Hirsch I, Sproule S, Robb ML, Corey L, Neuzil KM, Hahn W, Hunt J, Mulligan MJ, McEvoy C, DeJesus E, Hassman M, Little SJ, Pahud BA, Durbin A, Pickrell P, Daar ES, Bush L, Solis J, Carr QO, Oyedele T, Buchbinder S, Cowden J, Vargas SL, Guerreros Benavides A, Call R, Keefer MC, Kirkpatrick BD, Pullman J, Tong T, Brewinski Isaacs M, Benkeser D, Janes HE, Nason MC, Green JA, Kelly EJ, Maaske J, Mueller N, Shoemaker K, Takas T, Marshall RP, Pangalos MN, Villafana T, Gonzalez-Lopez A; AstraZeneca AZD1222 Clinical Study Group. Falsey AR, et al. N Engl J Med. 2021 Dec 16;385(25):2348-2360. doi: 10.1056/NEJMoa2105290. Epub 2021 Sep 29. N Engl J Med. 2021. PMID: 34587382 Free PMC article. Clinical Trial.
Risk of COVID-19 after natural infection or vaccination.
Rick AM, Laurens MB, Huang Y, Yu C, Martin TCS, Rodriguez CA, Rostad CA, Maboa RM, Baden LR, El Sahly HM, Grinsztejn B, Gray GE, Gay CL, Gilbert PB, Janes HE, Kublin JG, Huang Y, Leav B, Hirsch I, Struyf F, Dunkle LM, Neuzil KM, Corey L, Goepfert PA, Walsh SR, Follmann D, Kotloff KL; NIAID-funded COVID-19 Prevention Network (CoVPN). Rick AM, et al. EBioMedicine. 2023 Oct;96:104799. doi: 10.1016/j.ebiom.2023.104799. Epub 2023 Sep 20. EBioMedicine. 2023. PMID: 37738833 Free PMC article. Clinical Trial.
Deep learning methods in metagenomics: a review.
Roy G, Prifti E, Belda E, Zucker JD. Roy G, et al. Microb Genom. 2024 Apr;10(4):001231. doi: 10.1099/mgen.0.001231. Microb Genom. 2024. PMID: 38630611 Free PMC article. Review.
Impact of HLA class I functional divergence on HIV control.
Viard M, O'hUigin C, Yuki Y, Bashirova AA, Collins DR, Urbach JM, Wolinsky S, Buchbinder S, Kirk GD, Goedert JJ, Michael NL, Haas DW, Deeks SG, Walker BD, Yu X, Carrington M. Viard M, et al. Science. 2024 Jan 19;383(6680):319-325. doi: 10.1126/science.adk0777. Epub 2024 Jan 18. Science. 2024. PMID: 38236978 Free PMC article.
Severe Monkeypox in Hospitalized Patients - United States, August 10-October 10, 2022.
Miller MJ, Cash-Goldwasser S, Marx GE, Schrodt CA, Kimball A, Padgett K, Noe RS, McCormick DW, Wong JM, Labuda SM, Borah BF, Zulu I, Asif A, Kaur G, McNicholl JM, Kourtis A, Tadros A, Reagan-Steiner S, Ritter JM, Yu Y, Yu P, Clinton R, Parker C, Click ES, Salzer JS, McCollum AM, Petersen B, Minhaj FS, Brown E, Fischer MP, Atmar RL, DiNardo AR, Xu Y, Brown C, Goodman JC, Holloman A, Gallardo J, Siatecka H, Huffman G, Powell J, Alapat P, Sarkar P, Hanania NA, Bruck O, Brass SD, Mehta A, Dretler AW, Feldpausch A, Pavlick J, Spencer H, Ghinai I, Black SR, Hernandez-Guarin LN, Won SY, Shankaran S, Simms AT, Alarcón J, O'Shea JG, Brooks JT, McQuiston J, Honein MA, O'Connor SM, Chatham-Stephens K, O'Laughlin K, Rao AK, Raizes E, Gold JAW, Morris SB; CDC Severe Monkeypox Investigations Team. Miller MJ, et al. MMWR Morb Mortal Wkly Rep. 2022 Nov 4;71(44):1412-1417. doi: 10.15585/mmwr.mm7144e1. MMWR Morb Mortal Wkly Rep. 2022. PMID: 36327164 Free PMC article.
Approaching monkeypox: a guide for clinicians.
Torres HM, Ellsworth G, Zucker J, Glesby MJ. Torres HM, et al. Top Antivir Med. 2022 Oct;30(4):575-581. Top Antivir Med. 2022. PMID: 36375131 Free PMC article.
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5.
Wang Q, Guo Y, Iketani S, Nair MS, Li Z, Mohri H, Wang M, Yu J, Bowen AD, Chang JY, Shah JG, Nguyen N, Chen Z, Meyers K, Yin MT, Sobieszczyk ME, Sheng Z, Huang Y, Liu L, Ho DD. Wang Q, et al. Nature. 2022 Aug;608(7923):603-608. doi: 10.1038/s41586-022-05053-w. Epub 2022 Jul 5. Nature. 2022. PMID: 35790190 Free PMC article.
The challenge of HIV-1 subtype diversity.
Taylor BS, Sobieszczyk ME, McCutchan FE, Hammer SM. Taylor BS, et al. N Engl J Med. 2008 Apr 10;358(15):1590-602. doi: 10.1056/NEJMra0706737. N Engl J Med. 2008. PMID: 18403767 Free PMC article. Review. No abstract available.
181 results